Dawn Christine Maroney Sells 30,000 Shares of Alignment Healthcare (NASDAQ:ALHC) Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) President Dawn Christine Maroney sold 30,000 shares of the stock in a transaction on Friday, May 15th. The stock was sold at an average price of $16.09, for a total value of $482,700.00. Following the transaction, the president owned 998,813 shares of the company’s stock, valued at $16,070,901.17. This represents a 2.92% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Dawn Christine Maroney also recently made the following trade(s):

• On Wednesday, April 15th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $20.87, for a total value of $626,100.00.
• On Wednesday, March 18th, Dawn Christine Maroney sold 36,749 shares of Alignment Healthcare stock. The stock was sold at an average price of $17.84, for a total value of $655,602.16.
• On Monday, March 16th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $17.48, for a total value of $524,400.00.
• On Thursday, March 12th, Dawn Christine Maroney sold 29,113 shares of Alignment Healthcare stock. The stock was sold at an average price of $17.45, for a total value of $508,021.85.

Alignment Healthcare Stock Performance

Alignment Healthcare stock opened at $16.66 on Thursday. The company has a debt-to-equity ratio of 1.56, a current ratio of 1.58 and a quick ratio of 1.58. The stock has a fifty day moving average price of $18.90 and a two-hundred day moving average price of $19.44. Alignment Healthcare, Inc. has a 52-week low of $11.63 and a 52-week high of $23.87. The firm has a market capitalization of $3.44 billion, a P/E ratio of 185.11, a P/E/G ratio of 2.29 and a beta of 1.26.

Alignment Healthcare (NASDAQ:ALHC) last released its quarterly earnings data on Thursday, April 30th. The company reported $0.05 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.01 by $0.04. Alignment Healthcare had a return on equity of 11.50% and a net margin of 0.47%.The firm had revenue of $1.24 billion during the quarter, compared to analyst estimates of $1.22 billion. During the same period in the prior year, the company posted ($0.05) earnings per share. The business’s revenue for the quarter was up 33.3% compared to the same quarter last year. As a group, analysts anticipate that Alignment Healthcare, Inc. will post 0.19 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several analysts have recently commented on the company. Raymond James Financial set a $22.00 target price on Alignment Healthcare in a report on Thursday, May 7th. Zacks Research upgraded Alignment Healthcare from a “hold” rating to a “strong-buy” rating in a report on Tuesday, April 28th. Robert W. Baird set a $28.00 target price on Alignment Healthcare in a report on Friday, January 30th. Barclays increased their target price on Alignment Healthcare from $18.00 to $19.00 and gave the stock an “equal weight” rating in a report on Friday, May 1st. Finally, JPMorgan Chase & Co. increased their target price on Alignment Healthcare from $23.00 to $26.00 and gave the stock an “overweight” rating in a report on Thursday, February 5th. Two equities research analysts have rated the stock with a Strong Buy rating, six have assigned a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $24.60.

Institutional Investors Weigh In On Alignment Healthcare

Hedge funds have recently modified their holdings of the business. Summit Securities Group LLC acquired a new stake in shares of Alignment Healthcare during the fourth quarter worth about $26,000. Parallel Advisors LLC raised its position in shares of Alignment Healthcare by 87.7% during the fourth quarter. Parallel Advisors LLC now owns 1,654 shares of the company’s stock worth $33,000 after purchasing an additional 773 shares during the period. Larson Financial Group LLC acquired a new stake in shares of Alignment Healthcare during the third quarter worth about $33,000. First Horizon Corp acquired a new stake in shares of Alignment Healthcare during the fourth quarter worth about $39,000. Finally, GAMMA Investing LLC raised its position in shares of Alignment Healthcare by 83.8% during the fourth quarter. GAMMA Investing LLC now owns 2,165 shares of the company’s stock worth $43,000 after purchasing an additional 987 shares during the period. Institutional investors and hedge funds own 86.19% of the company’s stock.

About Alignment Healthcare

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.